Evidence map›Paper›PMID 12523661›Full record

ArticlePharmaceutical research2002

Multivariate statistics of disposition pharmacokinetic parameters for structurally unrelated drugs used in therapeutics.

Vangelis Karalis, Anna Tsantili-Kakoulidou, Panos Macheras

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vangelis KaralisLaboratory of Biopharmaceutics-Pharmacokinetics, School of Pharmacy, University of Athens, Athens, Greece.
Anna Tsantili-Kakoulidou
Panos Macheras

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo explore the quantitative structure pharmacokinetic relationships of the disposition parameters: clearance (CL), apparent volume of drug distribution (V(ap)), fractal clearance (CL(f)), and fractal volume (v(f)) for 272 structurally unrelated drugs used in therapeutics.

methodsLiterature data were used for CL and V(ap) whereas CL(f) and v(f) were estimated as described previously (Pharm. Res. 18, 1056, 2001 and 19, 697, 2002). A variety of molecular descriptors expressing lipophilicity, ionization, molecular size and hydrogen bonding capacity were estimated using computer packages. The data were analyzed using multivariate statistics. For each disposition parameter (CL, V(ap) CL(f), v(f)) PCA (principal component analysis) and PLS (projection to latent structures) were applied to the total set of data as well as to subsets of data.

resultsDrugs were divided into two classes (I and II) according to their v(f)/V(ap) ratio. Class I comprises 131 drugs with v(f)/V(ap) > 1, whereas class 11141 drugs with v(f)/V(ap) < 1. After initial PLS analysis, class I was subdivided in subclusters I(a) (30 drugs) and I(b) (101 drugs). It was found that I(a) included mostly acidic drugs with high protein binding, whereas class II comprises mainly basic, lipophilic compounds. No correlation was found between CL, V(ap), CL(f) and the used descriptors. Adequate PLS models were derived for v(f) considering subclusters I(a), I(b) and class II separately. The low v(f) values of class I(a) drugs were affected negatively from molecular size descriptors and non-polar surface area. For class I(b) drugs with intermediate v(f) values, apparent lipophilicity contributed positively, although molecular size descriptors and polarity were inhibitory factors. The high v(f) values of class II drugs were positively dependent on intrinsic lipophilicity and increased basicity, whereas polarity entered with negative contribution.

conclusionsThe parameters V(ap), CL, and CL(f) fail to reflect the physicochemical properties of drugs. The transformation of V(ap) values to v(f) is the underlying cause for the valid models for v(f). These models allow a global consideration of molecular properties (lipophilicity, ionization, molecular size, polar surface area) which govern the distribution of drugs in the human body. The present study provides additional evidence for the physiologically sound concept of v(f).

Indexed as

Models, MolecularMultivariate AnalysisPrincipal Component AnalysisBiological AvailabilityPharmaceutical PreparationsStructure-Activity RelationshipPharmaceutical Preparations

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.